ISIS-5132/CGP69846A antisense phosphorothioate oligonucleotide: ISIP began a Phase I trial

Isis Pharmaceuticals (ISIP), Carlsbad, Calif. Product: ISIS-5132/CGP69846A antisense phosphorothioate oligonucleotide Indication: Solid tumors Status: ISIP began a Phase I trial in patients with a var...